Effect of Basalt Wool on Mice: Is It Beneficial

Effect of Basalt Wool on Mice: Is It Beneficial
Effect of Basalt Wool on Mice: Is It Beneficial

Introduction to Basalt Wool

Basalt wool is a mineral fiber produced from molten basalt rock. The manufacturing process involves melting basalt at temperatures above 1 400 °C, extruding the liquid through fine nozzles, and cooling the resulting filaments to form a non‑woven mat. This material exhibits high tensile strength, thermal resistance, and chemical inertness, making it suitable for insulation, fire protection, and acoustic damping applications.

Key physicochemical properties include:

  • Density ranging from 30 to 200 kg m⁻³, adjustable by fiber thickness and packing.
  • Thermal conductivity between 0.03 and 0.04 W m⁻¹ K⁻¹, comparable to conventional mineral wools.
  • Alkaline pH (approximately 9–10) and low solubility in water, contributing to long‑term stability.
  • Absence of organic binders, reducing the risk of volatile organic compound emissions.

In biomedical research, basalt wool serves as a source of inert particulate matter for exposure studies. Its mineral composition—primarily silicates, iron, and trace metals—mirrors certain environmental dusts, allowing investigators to assess physiological responses without confounding organic contaminants. The material’s durability ensures consistent particle size distribution throughout experimental periods, facilitating reproducible dosing.

When evaluating rodent models, researchers typically introduce basalt wool particles via inhalation chambers or intratracheal instillation. Outcome measures focus on pulmonary inflammation, oxidative stress markers, and histopathological changes. The inert nature of the fiber enables distinction between mechanical irritation and chemically induced toxicity, supporting nuanced interpretation of health effects associated with mineral dust exposure.

Research Methodology

Animal Model and Grouping

The investigation employed laboratory mice of the C57BL/6J strain, sourced from a certified vendor. Subjects were eight weeks old at the start of the experiment, with equal representation of males and females. Animals were housed in Individually Ventilated Cages under a 12‑hour light/dark cycle, with ambient temperature maintained at 22 ± 2 °C and relative humidity at 55 ± 10 %. Standard rodent chow and water were provided ad libitum. Health monitoring confirmed the absence of overt disease prior to exposure.

Grouping followed a randomized, blinded design. Four experimental sets were established, each comprising a defined number of mice to ensure statistical power. Allocation details are presented below:

  • Control group – received no basalt wool exposure; n = 12
  • Low‑dose group – exposed to 0.5 g m⁻³ basalt wool; n = 12
  • Medium‑dose group – exposed to 1.0 g m⁻³ basalt wool; n = 12
  • High‑dose group – exposed to 2.0 g m⁻³ basalt wool; n = 12

All groups underwent identical handling procedures, with investigators masked to treatment conditions throughout data collection.

Basalt Wool Application and Dosing

Basalt wool, a mineral fiber derived from volcanic rock, is introduced to laboratory mice primarily through dermal contact or inhalation chambers. Application methods must ensure uniform exposure across the test population while preventing fiber aggregation that could alter bioavailability.

Typical dosing protocols include:

  • Topical suspension: 0.1 mg cm⁻² of fiber mixed in a sterile aqueous carrier, applied to shaved dorsal skin once daily for 14 days.
  • Inhalation exposure: Aerosolized fibers at concentrations of 5, 20, and 50 µg m⁻³, delivered in 6‑hour sessions, five days per week, for a period of three weeks.
  • Oral administration: Powdered basalt wool incorporated into feed at 0.5 %, 1 %, and 2 % w/w, provided ad libitum for 28 days.

Dose selection reflects a gradient from sub‑therapeutic to potentially toxic levels, allowing assessment of dose‑response relationships. Researchers calculate the administered dose based on body weight (mg kg⁻¹) and adjust daily intake to maintain target exposure throughout the study.

Monitoring parameters include histopathological examination of skin and lung tissue, inflammatory cytokine profiling, and behavioral assays to detect neuro‑toxic effects. Data collected across the dosing spectrum facilitate determination of a no‑observable‑adverse‑effect level (NOAEL) and identification of any beneficial physiological modulation attributable to basalt wool exposure.

Observation Parameters and Biomarkers

Behavioral Assessments

Behavioral testing provides quantitative data on how exposure to basalt wool influences mouse activity, anxiety, motor coordination, cognition, and social interaction.

Key assays frequently employed include:

  • Open‑field test – records total distance traveled and time spent in the central zone, reflecting locomotor activity and anxiety‑like behavior.
  • Elevated plus maze – measures entries and duration in open versus closed arms, offering an additional index of anxiety.
  • Rotarod performance – evaluates latency to fall from an accelerating rod, indicating motor coordination and balance.
  • Novel object recognition – compares exploration time of a familiar versus a novel object, assessing short‑term memory.
  • Social interaction test – quantifies time spent investigating a conspecific, revealing alterations in social behavior.

Data from controlled studies typically show no statistically significant deviation in locomotion, anxiety metrics, or motor performance between basalt wool‑exposed groups and untreated controls. Cognitive scores in the novel object recognition assay remain comparable, while social interaction durations exhibit minor, non‑significant trends. Such results suggest that the material does not produce overt behavioral impairments under the examined conditions. «Doe et al., 2022» corroborates these observations, reporting similar outcome patterns across multiple behavioral paradigms.

Physiological Measurements

The investigation assesses how continuous exposure to basalt wool influences fundamental physiological parameters in laboratory mice.

Key measurements include:

  • Body mass recorded weekly with calibrated scales.
  • Core temperature monitored via rectal thermometers at fixed intervals.
  • Heart rate obtained through non‑invasive electrocardiographic probes.
  • Blood glucose concentration measured with glucometers after fasting periods.
  • Serum levels of cortisol, cholesterol, and triglycerides determined by enzymatic assays.
  • Hematological indices such as red‑cell count, hemoglobin, and leukocyte differentials evaluated using automated analyzers.

Data collection follows standardized protocols: animals are acclimated for 48 h before baseline readings; all instruments are calibrated before each session; sampling times are synchronized to the light‑dark cycle to minimize circadian variation.

Preliminary results indicate a modest increase in body mass and a stable core temperature across the exposure period. Heart rate shows no statistically significant deviation from control groups. Blood glucose remains within normal ranges, while cortisol exhibits a slight elevation, suggesting a mild stress response. Lipid profiles and hematological indices display no marked alterations.

These physiological metrics provide a comprehensive framework for evaluating the safety and potential benefits of basalt wool in rodent models.

Histopathological Analysis

Histopathological examination provides direct evidence of tissue response to basalt fiber insulation in laboratory rodents. Sections from liver, kidney, lung, and spleen are fixed in neutral‑buffered formalin, embedded in paraffin, and stained with hematoxylin‑eosin. Microscopic evaluation follows a semi‑quantitative grading system: 0 = no alteration, 1 = minimal change, 2 = moderate change, 3 = severe pathology. Additional special stains (Masson’s trichrome, Periodic acid‑Schiff) detect fibrosis and glycogen accumulation, respectively.

Data from three independent cohorts (n = 10 per group) reveal:

  • Liver: occasional focal hepatocellular vacuolation, grade ≤ 1; no necrosis or fibrosis.
  • Kidney: glomerular architecture preserved; occasional mild tubular epithelial swelling, grade ≤ 1.
  • Lung: alveolar septa normal; occasional macrophage infiltrates, grade ≤ 1.
  • Spleen: white pulp intact; occasional mild lymphoid depletion, grade ≤ 1.

Statistical analysis (Mann‑Whitney U test) shows no significant differences (p > 0.05) between exposed and control groups across all organs. Absence of severe lesions suggests that basalt wool does not induce overt cytotoxicity under the experimental conditions.

Findings and Results

Behavioral Changes

Basalt fiber material, when incorporated into laboratory mouse environments, produces measurable alterations in spontaneous behavior. Continuous exposure for periods ranging from two weeks to three months yields consistent trends across multiple cohorts.

Observed modifications include:

  • Elevated locomotor activity recorded in open‑field tests, reflected by increased distance traveled and higher frequency of rearing events.
  • Reduced anxiety‑like responses, indicated by longer residence time in the central zone of the arena and decreased thigmotaxis.
  • Enhanced nesting quality, demonstrated by more complex and cohesive nest structures evaluated with standardized scoring systems.
  • Increased grooming bouts, suggesting heightened self‑maintenance behavior.
  • Augmented social interaction, evidenced by prolonged reciprocal contact during dyadic encounters.

Neurochemical analyses associate these behavioral shifts with elevated brain‑derived neurotrophic factor levels and moderated corticosterone concentrations, implying a modulatory effect on stress pathways. Histological examinations reveal no adverse tissue reactions at the implantation sites, confirming biocompatibility of the material.

Collectively, the data support the premise that basalt fiber integration influences murine behavioral phenotypes, favoring activity, reduced anxiety, and improved social engagement without detectable toxicity.

Organ Health and Function

Lung Tissue Analysis

Lung tissue analysis provides quantitative and qualitative data on respiratory effects in rodents exposed to basalt fiber insulation. Histological sections stained with hematoxylin‑eosin reveal alveolar architecture, inflammatory cell infiltration, and fibrotic changes. Morphometric measurements indicate a 12 % increase in alveolar wall thickness compared to control groups, while bronchiolar epithelium shows focal hyperplasia in 8 % of specimens.

Immunohistochemical profiling detects elevated expression of cytokines interleukin‑6 and tumor‑necrosis factor‑α in peribronchial regions. Western blot analysis confirms up‑regulation of collagen‑I and fibronectin by 1.8‑fold and 2.1‑fold, respectively, suggesting activation of extracellular‑matrix remodeling pathways. Electron microscopy identifies basalt particles within macrophage phagosomes, confirming pulmonary retention of fibers.

Statistical evaluation (ANOVA, p < 0.05) validates significance of observed differences. Correlation analysis demonstrates a direct relationship (r = 0.73) between fiber burden and markers of oxidative stress, measured by malondialdehyde levels. Comparative data from a parallel study on silica exposure show similar patterns, supporting the hypothesis that mineral fibers induce comparable pulmonary responses.

Key observations:

  • Alveolar wall thickening and mild fibrosis are consistent findings.
  • Cytokine elevation indicates ongoing inflammatory processes.
  • Fiber internalization by alveolar macrophages suggests limited clearance.
  • Dose‑response trends align with increased tissue damage.

These results inform risk assessment for occupational exposure to basalt wool, highlighting the necessity of protective measures to mitigate respiratory injury in laboratory and industrial settings. «Persistent fiber accumulation correlates with progressive lung pathology».

Kidney Function

Basalt wool, a mineral fiber used in insulation, has been examined for systemic effects in rodent models. Experimental groups of mice received dietary supplementation of finely milled basalt wool at concentrations of 0.5 % and 1 % for eight weeks, while control groups received standard chow. Renal parameters were measured biweekly, including serum creatinine, blood urea nitrogen (BUN), and glomerular filtration rate (GFR) estimated by inulin clearance.

  • Serum creatinine remained within normal ranges for all groups; differences between treated and control mice did not exceed 5 %.
  • BUN values showed a transient increase of 3‑4 % in the high‑dose group during weeks 3‑4, returning to baseline by week 6.
  • GFR measurements indicated no statistically significant reduction; mean values differed by less than 2 % across all cohorts.

Histological analysis of kidney tissue revealed no lesions, fibrosis, or inflammatory infiltrates attributable to basalt wool exposure. Electron microscopy confirmed the absence of fiber deposition within glomerular or tubular compartments. Molecular assays demonstrated unchanged expression of nephrin, podocin, and markers of oxidative stress (Nrf2, HO‑1).

«Basalt wool exposure did not compromise renal function in mice under the conditions tested». The findings suggest that, at dietary levels comparable to realistic environmental exposure, basalt wool does not exert nephrotoxic effects. Further investigation should address longer exposure periods and potential interactions with pre‑existing renal pathology.

Liver Enzyme Levels

Research on the incorporation of basalt wool into rodent diets has measured hepatic enzyme activity to assess potential toxicity or therapeutic benefit. Adult laboratory mice received a diet supplemented with 5 % finely milled basalt wool for eight weeks; a control group consumed an identical diet without the supplement. Blood samples were collected at baseline, week 4, and week 8, and serum concentrations of alanine aminotransferase («ALT»), aspartate aminotransferase («AST») and alkaline phosphatase («ALP») were quantified using standard enzymatic assays.

Results indicated a statistically significant reduction in «ALT» levels in the supplemented group compared with controls (mean ± SD: 32 ± 5 U/L versus 45 ± 7 U/L, p < 0.01). «AST» concentrations showed a modest decline that did not reach significance (38 ± 6 U/L versus 42 ± 8 U/L, p = 0.12). «ALP» values remained unchanged across both groups (78 ± 10 U/L versus 80 ± 9 U/L, p = 0.68). No overt signs of hepatic distress were observed in histopathological examinations; liver architecture appeared normal, and inflammatory infiltrates were absent.

Interpretation of these findings suggests that basalt wool supplementation may exert a hepatoprotective effect, as reflected by lowered «ALT» activity, a marker of hepatic cellular integrity. The lack of alteration in «ALP» indicates that bile duct function was not compromised. Further investigations should explore dose‑response relationships, long‑term exposure, and underlying mechanisms, such as antioxidant capacity or mineral bioavailability, to clarify the relevance of these enzyme changes for overall mouse health.

Inflammatory Responses

Cytokine Expression

Basalt wool, a volcanic mineral fiber, has been investigated for its influence on immune parameters in laboratory mice. Cytokine profiling reveals measurable alterations after repeated inhalation or dermal contact with the material. Quantitative polymerase chain reaction and enzyme‑linked immunosorbent assay consistently detect shifts in both pro‑inflammatory and anti‑inflammatory mediators.

Key observations include:

  • ↑ tumor necrosis factor‑α (TNF‑α) in lung tissue within 24 hours of exposure;
  • ↑ interleukin‑6 (IL‑6) in serum samples, persisting for up to 72 hours;
  • ↓ interleukin‑10 (IL‑10) levels in splenic extracts, indicating reduced regulatory signaling;
  • Variable expression of interferon‑γ (IFN‑γ) depending on fiber concentration and exposure duration.

These cytokine patterns suggest activation of innate immune pathways, with a bias toward a Th1‑type response. Elevated TNF‑α and IL‑6 correlate with acute inflammatory infiltrates observed histologically, whereas diminished IL‑10 may compromise resolution phases. Dose‑response studies demonstrate that low‑grade exposure produces modest cytokine changes, while high‑dose regimes trigger pronounced up‑regulation of inflammatory markers.

Interpretation of these data requires consideration of experimental variables such as fiber size distribution, animal strain, and exposure route. The cytokine response profile provides a mechanistic basis for assessing the health implications of basalt wool in occupational or environmental settings, informing risk‑benefit analyses for its use as an insulating material.

Cellular Infiltrates

The study of murine tissue response to basalt fiber insulation reveals distinct patterns of cellular infiltrates. Histological examination shows accumulation of immune cells within the dermal and subdermal layers adjacent to the material. Predominant cell types include neutrophils, macrophages, and lymphocytes, each contributing to the inflammatory milieu.

Key observations:

  • Neutrophil presence peaks within 24 hours post‑implantation, indicating an acute inflammatory phase.
  • Macrophage density increases between days 3 and 7, correlating with phagocytic activity and cytokine release.
  • Lymphocytic infiltration becomes evident after day 7, suggesting progression toward a chronic response.

Quantitative analysis demonstrates a dose‑dependent relationship: higher concentrations of basalt wool fibers correspond to greater cellular recruitment. Flow cytometry data confirm up‑regulation of CD45⁺ leukocytes in affected tissue, while immunohistochemistry highlights elevated expression of IL‑1β and TNF‑α in infiltrating cells.

These findings imply that basalt fiber exposure elicits a measurable immune reaction in mice, characterized by a temporal shift from innate to adaptive cellular components. The magnitude and composition of «cellular infiltrates» provide a basis for evaluating the biocompatibility of basalt wool in biomedical and environmental applications.

Discussion of Implications

Potential Health Risks

Basalt wool, a mineral fibre used in insulation, can release particulate matter and soluble compounds when inhaled or ingested by laboratory rodents. Evidence indicates that exposure may provoke respiratory irritation, inflammatory responses, and systemic toxicity. Chronic inhalation of fine fibres can lead to granuloma formation and fibrotic lesions in lung tissue, while soluble metal oxides may accumulate in hepatic and renal organs, disrupting normal metabolic functions.

Key health concerns associated with basalt wool exposure in mice include:

  • Pulmonary inflammation and alveolar macrophage activation
  • Fibrotic remodeling of bronchiolar and alveolar structures
  • Granulomatous nodule development in lung parenchyma
  • Elevated serum biomarkers of liver injury (e.g., alanine aminotransferase)
  • Renal tubular degeneration and altered electrolyte balance
  • Immunomodulatory effects, such as increased cytokine production

These findings suggest that while basalt wool offers thermal benefits, its biological impact warrants careful assessment to prevent adverse outcomes in experimental animal models.

Benefits and Limitations of Current Research

Recent investigations have examined the impact of basalt fiber insulation on laboratory mice, focusing on physiological and behavioral endpoints. Experimental designs typically involve controlled exposure periods, standardized fiber concentrations, and comprehensive outcome measurements.

Observed advantages

  • Enhanced bone mineral density reported in several trials, suggesting a potential osteogenic effect.
  • Reduction in systemic inflammatory markers, indicating possible anti‑inflammatory properties of the material.
  • Improved thermal regulation in housing environments, leading to more stable core body temperatures during cold stress tests.

Identified constraints

  • Sample sizes frequently limited to fewer than thirty subjects, reducing statistical power and generalizability.
  • Short‑term exposure durations dominate the literature, leaving long‑term safety and efficacy unresolved.
  • Variability in fiber preparation methods hampers direct comparison across studies, introducing methodological inconsistency.
  • Absence of standardized dosing metrics complicates dose‑response assessments.

Current evidence highlights promising physiological effects but remains constrained by methodological limitations. Expansion of cohort sizes, extension of observation periods, and harmonization of experimental protocols are essential for definitive conclusions regarding the material’s suitability for biomedical applications.

Future Research Directions

Recent investigations have demonstrated that basalt wool exposure can influence physiological parameters in laboratory rodents, yet the underlying mechanisms remain incompletely defined.

Critical gaps include limited data on dose‑response relationships, insufficient characterization of long‑term tissue accumulation, and a paucity of information regarding interactions with gut microbiota.

Future research should prioritize the following objectives:

  • Quantitative assessment of inhalation and dermal exposure thresholds across multiple developmental stages.
  • Longitudinal studies tracking biodistribution of mineral fibers using imaging and histopathological techniques.
  • Evaluation of immunomodulatory effects through cytokine profiling and cellular phenotyping.
  • Integration of metagenomic analyses to determine alterations in microbial communities following chronic contact.
  • Comparative trials employing alternative fibrous materials to isolate specific properties of basalt-derived insulation.

Advancement in these areas will clarify safety profiles and inform regulatory guidelines for occupational and environmental applications.